Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Verrica Pharmaceuticals (VRCA) Q3 2026 Earnings
VRCA
6
Aug
Confirmed
Q3 2025
Q4 2025
Q2 2026
Q3 2026
-0.9
-0.59
-0.29
0.02
Details
Expected EPS
-0.3875
Actual EPS
-0.62
Surprise EPS
-0.23
Surprise Percent
+60%
Description
Verrica Pharmaceuticals (VRCA) has reported earnings of -0.62 per share for Q3 2026.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login